title: Sleeve gastrectomy and gastro-oesophageal reflux disease: a complex relationship.
abstract: Sleeve gastrectomy is rapidly becoming popular as a standalone bariatric operation. At the same time, there are valid concerns regarding its long-term durability and postoperative gastro-oesophageal reflux disease. Though gastric bypass remains the gold standard bariatric operation, it is not suitable for all patients. Sleeve gastrectomy is sometimes the only viable option. Patients with inflammatory bowel disease, liver cirrhosis, significant intra-abdominal adhesions involving small bowel and those reluctant to undergo gastric bypass could fall in this category. It is widely recognised that some patients report worsening of their gastro-oesophageal reflux disease after sleeve gastrectomy. Still, others develop de novo reflux. This review examines if it is possible to identify these patients prior to surgery and thus prevent postoperative gastro-oesophageal reflux disease after sleeve gastrectomy.
authors: Bariatric Unit, Sunderland Royal Hospital, Sunderland, SR4 7TP, UK. kamal_mahawar@hotmail.com
authors: Kamal K
authors: KK
authors: Mahawar
authors: Neil
authors: N
authors: Jennings
authors: Shlok
authors: S
authors: Balupuri
authors: Peter K
authors: PK
authors: Small
mesh_terms: D005260:Female; D005743:Gastrectomy / Q000009:adverse effects* / Q000379:methods; D005746:Gastric Emptying; D005764:Gastroesophageal Reflux / Q000209:etiology* / Q000503:physiopathology; D006551:Hernia, Hiatal / Q000150:complications; D006801:Humans; D008297:Male; D009767:Obesity, Morbid / Q000150:complications* / Q000503:physiopathology / Q000601:surgery*; D018579:Patient Selection; D018570:Risk Assessment; D016896:Treatment Outcome; D006113:United Kingdom; D015431:Weight Loss